Lantadene B

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 598379

CAS#: 467-82-3

Description: Lantadene B is an active principle of Lantana camara L.

Chemical Structure

img
Lantadene B
CAS# 467-82-3
Instruction

Theoretical Analysis

MedKoo Cat#: 598379
Name: Lantadene B
CAS#: 467-82-3
Chemical Formula: C35H52O5
Exact Mass: 552.38
Molecular Weight: 552.790
Elemental Analysis: C, 76.05; H, 9.48; O, 14.47

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Lantadene B; HSDB 3504;

IUPAC/Chemical Name: (4R,4aS,6aS,6bR,8aR,12aR,12bR,14bS)-2,2,6a,6b,9,9,12a-heptamethyl-4-((3-methylbut-2-enoyl)oxy)-10-oxo-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2H)-carboxylic acid

InChi Key: VYPAPFHUHDWCBI-QQAPFUPGSA-N

InChi Code: InChI=1S/C35H52O5/c1-21(2)18-28(37)40-27-20-30(3,4)19-23-22-10-11-25-32(7)14-13-26(36)31(5,6)24(32)12-15-34(25,9)33(22,8)16-17-35(23,27)29(38)39/h10,18,23-25,27H,11-17,19-20H2,1-9H3,(H,38,39)/t23-,24-,25+,27+,32-,33+,34+,35-/m0/s1

SMILES Code: CC1(C)C(CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])CC(C)(C)C[C@@H](OC(/C=C(C)\C)=O)[C@@](C(O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H])=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 552.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: LOUW PG. Lantadene A, the active principle of Lantana camara L.; isolation of lantadene B, and the oxygen functions of lantadene A and lantadene B. Onderstepoort J Vet Sci Anim Ind. 1948 Mar;23(1-2):233-8. PubMed PMID: 18863442.

2: Dong Y, Zhang M, Ling B. [Antifeeding effects of crude lantadene from Lantana camara on Plutella xylostella and Spodoptera litura larvae]. Ying Yong Sheng Tai Xue Bao. 2005 Dec;16(12):2361-4. Chinese. PubMed PMID: 16515188.

3: Tailor NK, Jaiswal V, Lan SS, Lee HB, Sharma M. Synthesis, selective cancer cytotoxicity and mechanistic studies of novel analogs of lantadenes. Anticancer Agents Med Chem. 2013 Jul 1;13(6):957-66. PubMed PMID: 23293887.

4: Tailor NK, Boon HL, Sharma M. Synthesis and in vitro anticancer studies of novel C-2 arylidene congeners of lantadenes. Eur J Med Chem. 2013 Jun;64:285-91. doi: 10.1016/j.ejmech.2013.04.009. Epub 2013 Apr 10. PubMed PMID: 23644211.

5: Sharma S, Sharma OP, Singh B, Bhat TK. Biotransformation of lantadenes, the pentacyclic triterpenoid hepatotoxins of lantana plant, in guinea pig. Toxicon. 2000 Sep;38(9):1191-202. PubMed PMID: 10736473.

6: Sharma OP, Dawra RK, Makkar HP. Toxicity of isolated Lantana (Lantana camara L) constituents to male and female guinea pigs. Vet Hum Toxicol. 1989 Feb;31(1):10-3. PubMed PMID: 2711601.